EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

149 hedge funds and large institutions have $1.31B invested in Eagle Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+12
Holders Change %
+8.76%
% of All Funds
3.73%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.15%
New
31
Increased
48
Reduced
46
Closed
16
Calls
$20.7M
Puts
$18.4M
Net Calls
+$2.23M
Net Calls Change
-$8.96M
Name Holding Trade Value Shares
Change
Shares
Change %
GAM
26
Gotham Asset Management
New York
$6.94M +$3.8M +47,951 +121%
William Blair & Company
27
William Blair & Company
Illinois
$6.38M -$175K -2,200 -3%
Millennium Management
28
Millennium Management
New York
$5.97M +$5.97M +75,232 New
PC
29
Pier Capital
Connecticut
$5.96M -$1.52M -19,213 -20%
Citigroup
30
Citigroup
New York
$5.89M +$5.26M +66,303 +831%
Norges Bank
31
Norges Bank
Norway
$5.63M
Geode Capital Management
32
Geode Capital Management
Massachusetts
$5.61M +$184K +2,316 +3%
BIA
33
Biondo Investment Advisors
Pennsylvania
$5.04M +$5.04M +63,575 New
CS
34
Candriam SCA
Luxembourg
$4.92M -$397K -5,000 -7%
Principal Financial Group
35
Principal Financial Group
Iowa
$4.61M +$1.51K +19 +0%
PAM
36
Panagora Asset Management
Massachusetts
$4.58M +$55.9K +704 +1%
CWG
37
C WorldWide Group
Denmark
$4.25M -$2.37M -29,807 -36%
OM
38
Opaleye Management
Massachusetts
$3.97M -$1.59M -20,000 -29%
QI
39
QS Investors
New York
$3.88M -$890K -11,215 -19%
CIP
40
Chartwell Investment Partners
Pennsylvania
$3.87M +$3.87M +48,739 New
BIM
41
BlackRock Investment Management
Delaware
$3.43M +$565K +7,124 +20%
BG
42
Bellevue Group
Switzerland
$3.23M +$928K +11,700 +40%
Goldman Sachs
43
Goldman Sachs
New York
$3.21M +$1.08M +13,555 +50%
IAM
44
Iridian Asset Management
Connecticut
$3.15M +$992K +12,500 +46%
GC
45
Guggenheim Capital
Illinois
$3.12M -$2.84M -35,814 -48%
NIP
46
Nicholas Investment Partners
California
$2.95M +$2.95M +37,254 New
EI
47
EAM Investors
California
$2.94M +$2.94M +37,106 New
CS
48
Credit Suisse
Switzerland
$2.85M +$70.4K +887 +3%
Charles Schwab
49
Charles Schwab
California
$2.73M -$22K -277 -0.8%
Barclays
50
Barclays
United Kingdom
$2.68M -$2.45M -30,826 -48%